Physician profile
Clay B Hudson
NPI 1013930122
$543.58
in general payments reported to CMS, 2019-2025
13 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.13 · 2021: $74.78 · 2022: $54.31 · 2023: $98.99 · 2024: $128 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $399.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $96.09 | 2023-2025 | Novasure, Myosure Tissue Removal Device, Omni Hysteroscope |
| Astellas Pharma US INC | $93.12 | 2024-2025 | Veozah |
| Daiichi Sankyo INC. | $81.14 | 2020-2022 | |
| Exeltis, USA INC. | $56.25 | 2023-2025 | Slynd |
| Boston Scientific Corporation | $47.33 | 2023 | Varithena Administration Pack |
| Organon LLC | $41.12 | 2022-2024 | |
| Coopersurgical, INC. | $25.97 | 2021 | |
| Pfizer INC. | $18.46 | 2025 | |
| Smith+Nephew, INC. | $17.96 | 2024 | Pico 7 |
| Becton, Dickinson and Company | $17.83 | 2023 | Bd Affirm Vpiii Microbial Identification Test |
| Exact Sciences Corporation | $17.69 | 2025 | Cologuard Collection Kit |
| Shield Therapeutics INC | $16.49 | 2024 | |
| Merck Sharp & Dohme LLC | $14.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clay Hudson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.